Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04045691

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

Sponsor: Pierre Fabre Pharma GmbH

View on ClinicalTrials.gov

Summary

BERING-MELANOMA - designed as a prospective, longitudinal, non-interventional study - investigates real-world effectiveness, quality of life, safety and tolerability of encorafenib plus binimetinib in unresectable advanced or metastatic BRAF(Rapidly Accelerated Fibrosarcoma isoform B)-V600-mutant malignant melanoma after commercial availability of these two products in Germany, Austria and Switzerland. The study focusses on the documentation of the first and second line setting (i.e. after one line of prior checkpoint inhibition) by documenting patients treated according to the SmPC (Summary of Product Characteristics).

Official title: Encorafenib Plus Binimetinib in Patients With Locally Advanced, Unresectable or Metastatic BRAFV600-mutated Melanoma: a Multi-centric, Multinational, Prospective, Longitudinal, Non-interventional Study in Germany, Austria and Switzerland - BERING MELANOMA

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

750

Start Date

2019-10-17

Completion Date

2027-09

Last Updated

2021-01-19

Healthy Volunteers

No

Interventions

DRUG

Encorafenib

Observation of real-life treatment with encorafenib and binimetinib

DRUG

Binimetinib

Observation of real-life treatment with encorafenib and binimetinib

Locations (59)

11

Graz, Austria

13

Innsbruck, Austria

14

Klagenfurt, Austria

10

Linz, Austria

3

Linz, Austria

12

Salzburg, Austria

22

Vienna, Austria

53

Vienna, Austria

23

Wiener Neustadt, Austria

45

Ahaus, Germany

8

Aschaffenburg, Germany

56

Augsburg, Germany

51

Berlin, Germany

27

Bremerhaven, Germany

1

Buxtehude, Germany

43

Chemnitz, Germany

34

Donauwörth, Germany

49

Dresden, Germany

47

Duisburg, Germany

40

Erfurt, Germany

20

Essen, Germany

9

Gera, Germany

28

Giessen, Germany

42

Goslar, Germany

59

Göttingen, Germany

19

Hamburg, Germany

21

Hanover, Germany

2

Heidelberg, Germany

33

Karlsruhe, Germany

39

Kiel, Germany

29

Landshut, Germany

44

Leipzig, Germany

30

Ludwigshafen, Germany

4

Lübeck, Germany

46

Magdeburg, Germany

15

Mainz, Germany

5

Mannheim, Germany

57

Marburg, Germany

6

Minden, Germany

31

München, Germany

7

München, Germany

16

Münster, Germany

35

Münster, Germany

18

Nuremberg, Germany

50

Regensburg, Germany

41

Schorndorf, Germany

17

Schwerin, Germany

48

Stolberg, Germany

55

Trier, Germany

54

Tübingen, Germany

32

Zwickau, Germany

52

Bellinzona, Canton Ticino, Switzerland

38

Aarau, Switzerland

37

Bern, Switzerland

24

Chur, Switzerland

36

Lausanne, Switzerland

58

Lucerne, Switzerland

26

Winterthur, Switzerland

25

Zurich, Switzerland